Anna Golebiewska

Integrative multi-omics combined with functional pharmacological profiling in patient-derived organoids identifies personalized therapeutic vulnerabilities of adult high-grade gliomas Background: Precision medicine has transformed cancer treatment by tailoring therapies to specific molecular aberrations. Integrating high-resolution multi-omics with high-throughput functional profil...

Precision medicine in high-grade gliomas? Using high-throughput drug screen in #NORLUX patient-derived organoids multi-omics and machine learning, we assessed pharmacogenomics: www.biorxiv.org/content/10.1...
@fnr.lu, #precisionmedicine, #organoids, #drugscreen, #pharmacogenomics, #braintumors

Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomas Astrocytomas and oligodendrogliomas are slow-growing and treatment-sensitive IDH-mutant gliomas diagnosed at ages 30-50. Local tumor regrowth and treatment resistance is inevitable resulting in 3-10 y...

New preprint on longitudinal treatment response signatures in IDH-mutant glioma from the GLASS Consortium www.biorxiv.org/content/10.1...

📣 Have you heard? Registration for #EANO2025, taking place Oct 16-19, 2025 in #Prague (CZ) is open! Don’t miss out on this fantastic experience to meet experts in the field of #NeuroOncology. Early Bird fees available until July 31, 2025. 👉 eano.eu/eano2025/reg... #braincancer #medsky

New CAJAL course incoming!
Applications are now open #CancerNeuroscience (22 Sep – 10 Oct 2025) at the Bordeaux School of Neuroscience!
🔗More info: cajal-training.org/on-site/canc...
@varunvenkatesh.bsky.social, #AntonioPagano

🧠 Join the next #EANOYoungsters Journal Club on June 5, 16:30–17:30 CEST!
Discussing: "Rapid molecular profiling of CNS tumors" www.nature.com/articles/s41... (Patel et al., Nat Med 2025)
📍Free & open to all EANO members
🔗 www.eano.eu
#NeuroOncology #BrainTumors #JournalClub

One month left to register for the 2025 Early Career Researchers Conference!

In its fifth edition, this virtual conference has become a must-attend for early career researchers to discuss critical aspects of a scientific career in cancer research.

Don't miss it: eacr.org/conference/e...

Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics - Nature Genetics Comparison of paired primary and recurrent glioblastomas at the single-cell transcriptomic level describes molecular and cellular trajectories associated with tumor recurrence, highlighting extensive ...

1/ Truly excited to share our new study that I had to privilege to co-lead during my PhD alongside great friends and collaborators @masashi-nomura.bsky.social, @kevin-johnson.bsky.social and Luciano Garofano, published at Nature Genetics @natureportfolio.nature.com!

www.nature.com/articles/s41...

Registration is OPEN for the next edition of The Tumour Ecosystem! 🎉

Taking place next March in Bergamo, this conference will cover the latest advances in research of the tumour microenvironment.

Learn more and register now: eacr.org/conference/t...

After a sold-out 2023 event, Goodbye Flat Biology has moved to a larger venue in Essen, Germany to make sure more of you can join us for what promises to be another fantastic event!

Join us for 3 days of excellent science and networking:
eacr.org/conference/g...

Discover insights into human glial development in organoid models & brain cancer with Dr. Steven Sloan from Emory University School of Medicine. Don’t miss this opportunity to explore cutting-edge neuroscience research!
📅 Monday, March 24, 2025
⏰ 2:00 – 3:15 PM (Paris time)
📍 Zoom – Register now!

🚀Abstract submission for #EANO2025 is open! Share your #NeuroOncology research at the 20th #EANO Meeting in Prague, Oct 16-19, 2025. We can't wait to see your contributions!
🗓️ Deadline: April 30, 2025, 23:59 CEST.
🔗 Details: www.eano.eu/eano2025/abs...
#btsm #braintumor

On March 10, 2025, Net4Brain is hosting a virtual conference Modelling Minds: Innovations in Preclinical Brain Cancer Research!
Join us here: zoom.us/j/9888368827...
Whole program: net4brain-cost.eu/rushmore_eve...
#Net4Brain #CA22103 #BrainCancerResearch #PreclinicalModels

Marta de Lucas and Soumi Mukherjee, our PhD candidates, presented their research posters at the Brain Tumor Microenvironment Symposium at @institutducerveau.bsky.social . Very exciting projects exploring how chemotherapy and ultrasounds influence the tumor microenvironment in glioblastoma 🧠

📢 Don’t miss the Highlights of EANO/SNO 2024 Webinar! Join our experts as they discuss key abstracts from #EANO2024 (Glasgow) & #SNO2024 (Houston), covering the latest in #NeuroOncology.
🗓️ March 7, 2025
⏱️ 6:30-7.30pm CET
Register now: eano.eu/eanowebinar/

@neuroonc.bsky.social

For all funs of tumor plasticity: @EACR 's upcoming conference on persister cells. Do not miss the abstract deadline on 20th January.

🧵Just in time for
: New research from the Venkataramani lab @CellCellPress
maps how brain tumor cells create extensive neural networks in glioblastoma. Check out our paper here: authors.elsevier.com/sd/article/S...
@ekinreyhan.bsky.social

@svenjaktetzlaff.bsky.social

1/15

Poster for EACR conference on Cancer Neuroscience on 14-16 October, 2025 in Bilbao, Spain featuring various speakers.

SAVE THE DATE

Discuss the interactions between the nervous system and cancer in our first @helloeacr.bsky.social conference on #CancerNeuroscience next year!

🗓️ Oct. 14-16, 2025
📍Bilbao, Spain

📥 Abstracts due June 30, 2025
📥 Register by Sept. 15, 2025

For more info, visit eacr.org/conference/c...

Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored? The treatment of patients with glioblastoma remains a challenge. Several large clinical trials of the last decades have failed and had—in retrospect—been b

"A thoughtful continuation of the clinical development of immunotherapeutic strategies within the framework of clinical trials is required to provide relevant new insights that can eventually lead to a clear delineation of its value in clinical practice"

academic.oup.com/neuro-oncolo...